Hover
CARZEC, a potent antihypertensive agent with a dual mechanism of action. It is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure). With Carzec patient live 1.4 years longer on an average.
Indication
- In Hypertension (high blood pressure)
- Angina (hear related chest pain) & Heart Failure
Composition
Each film coated tablet contains : Carvedilol IP 6.25 mg
Direction of use
As advised by your doctor
